Autophosphorylation activates Dictyostelium myosin II heavy chain kinase A by providing a ligand for an allosteric binding site in the alpha-kinase domain
- PMID: 21071445
- PMCID: PMC3024756
- DOI: 10.1074/jbc.M110.177014
Autophosphorylation activates Dictyostelium myosin II heavy chain kinase A by providing a ligand for an allosteric binding site in the alpha-kinase domain
Abstract
Dictyostelium discoideum myosin II heavy chain kinase A (MHCK A), a member of the atypical α-kinase family, phosphorylates sites in the myosin II tail that block filament assembly. Here we show that the catalytic activity of A-CAT, the α-kinase domain of MHCK A (residues 552-841), is severely inhibited by the removal of a disordered C-terminal tail sequence (C-tail; residues 806-841). The key residue in the C-tail was identified as Thr(825), which was found to be constitutively autophosphorylated. Dephosphorylation of Thr(825) using shrimp alkaline phosphatase decreased A-CAT activity. The activity of a truncated A-CAT lacking Thr(825) could be rescued by P(i), phosphothreonine, and a phosphorylated peptide, but not by threonine, glutamic acid, aspartic acid, or an unphosphorylated peptide. These results focused attention on a P(i)-binding pocket located in the C-terminal lobe of A-CAT. Mutational analysis demonstrated that the P(i)-pocket was essential for A-CAT activity. Based on these results, it is proposed that autophosphorylation of Thr(825) activates ACAT by providing a covalently tethered ligand for the P(i)-pocket. Ab initio modeling studies using the Rosetta FloppyTail and FlexPepDock protocols showed that it is feasible for the phosphorylated Thr(825) to dock intramolecularly into the P(i)-pocket. Allosteric activation is predicted to involve a conformational change in Arg(734), which bridges the bound P(i) to Asp(762) in a key active site loop. Sequence alignments indicate that a comparable regulatory mechanism is likely to be conserved in Dictyostelium MHCK B-D and metazoan eukaryotic elongation factor-2 kinases.
Figures
Similar articles
-
Determinants for substrate phosphorylation by Dictyostelium myosin II heavy chain kinases A and B and eukaryotic elongation factor-2 kinase.Biochim Biophys Acta. 2008 Jun;1784(6):908-15. doi: 10.1016/j.bbapap.2008.03.001. Epub 2008 Mar 12. Biochim Biophys Acta. 2008. PMID: 18381083
-
Crystal structure of the alpha-kinase domain of Dictyostelium myosin heavy chain kinase A.Sci Signal. 2010 Mar 2;3(111):ra17. doi: 10.1126/scisignal.2000525. Sci Signal. 2010. PMID: 20197546 Free PMC article.
-
Dictyostelium myosin II heavy-chain kinase A is activated by autophosphorylation: studies with Dictyostelium myosin II and synthetic peptides.Biochemistry. 1990 Sep 25;29(38):8992-7. doi: 10.1021/bi00490a016. Biochemistry. 1990. PMID: 2176841
-
Signaling pathways regulating Dictyostelium myosin II.J Muscle Res Cell Motil. 2002;23(7-8):703-18. doi: 10.1023/a:1024467426244. J Muscle Res Cell Motil. 2002. PMID: 12952069 Review.
-
Regulation of Dictyostelium myosin I and II.Biochim Biophys Acta. 2001 Mar 15;1525(3):245-61. doi: 10.1016/s0304-4165(01)00110-6. Biochim Biophys Acta. 2001. PMID: 11257438 Review.
Cited by
-
Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase.Biochem J. 2012 Mar 15;442(3):681-92. doi: 10.1042/BJ20111530. Biochem J. 2012. PMID: 22216903 Free PMC article.
-
SIMS: a hybrid method for rapid conformational analysis.PLoS One. 2013 Jul 23;8(7):e68826. doi: 10.1371/journal.pone.0068826. Print 2013. PLoS One. 2013. PMID: 23935893 Free PMC article.
-
Rosetta FlexPepDock ab-initio: simultaneous folding, docking and refinement of peptides onto their receptors.PLoS One. 2011 Apr 29;6(4):e18934. doi: 10.1371/journal.pone.0018934. PLoS One. 2011. PMID: 21572516 Free PMC article.
-
Mass Spectrometric Analysis of TRPM6 and TRPM7 Phosphorylation Reveals Regulatory Mechanisms of the Channel-Kinases.Sci Rep. 2017 Feb 21;7:42739. doi: 10.1038/srep42739. Sci Rep. 2017. PMID: 28220887 Free PMC article.
-
Eukaryotic elongation factor 2 kinase as a drug target in cancer, and in cardiovascular and neurodegenerative diseases.Acta Pharmacol Sin. 2016 Mar;37(3):285-94. doi: 10.1038/aps.2015.123. Epub 2016 Jan 25. Acta Pharmacol Sin. 2016. PMID: 26806303 Free PMC article. Review.
References
-
- Côte G. P., Bukiejko U. (1987) J. Biol. Chem. 262, 1065–1072 - PubMed
-
- De La Roche M. A., Smith J. L., Betapudi V., Egelhoff T. T., Côté G. P. (2002) J. Muscle Res. Cell Motil. 23, 703–718 - PubMed
-
- Vaillancourt J. P., Lyons C., Côté G. P. (1988) J. Biol. Chem. 263, 10082–10087 - PubMed
-
- Lück-Vielmetter D., Schleicher M., Grabatin B., Wippler J., Gerisch G. (1990) FEBS Lett. 269, 239–243 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
